IDIikki Donner

Iikki Donner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iikki Donner has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Mervi Aavikko

    Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland

    3 shared publications
  • Riku Katainen

    Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland

    3 shared publications
  • Eero Pukkala

    Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland; Faculty of Social Sciences, University of Tampere, Tampere, Finland

    2 shared publications
  • Lauri A. Aaltonen

    Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

    2 shared publications
  • Anna Kuosmanen

    University of Helsinki

    1 shared publication
  • Eevi Kaasinen

    Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland

    1 shared publication

Latest Publications

  • Next-generation sequencing in a large pedigree segregating visceral artery aneurysms suggests potential role of COL4A1/COL4A2 in disease etiology

    by Iikki Donner, Lauri J Sipilä, Roosa-Maria Plaketti, Anna Kuosmanen, Linda Forsström, Riku Katainen, Outi Kuismin, Mervi Aavikko, Pekka Romsi, Juho Kariniemi, et al.

    Visceral artery aneurysms (VAAs) can be fatal if ruptured. Although a relatively rare incident, it holds a contemporary mortality rate of approximately 12%. VAAs have multiple possible causes, one of which is genetic predisposition. Here, we present a striking family with seven individuals affected by VAAs, and one individual affected by a visceral artery pseudoaneurysm. We exome sequenced the affected family members and the parents of the proband to find a possible underlying genetic defect. As exome sequencing did not reveal any feasible protein-coding variants, we combined whole-genome sequencing of two individuals with linkage analysis to find a plausible non-coding culprit variant. Variants were ranked by the deep learning framework DeepSEA. Two of seven top-ranking variants, NC_000013.11:g.108154659C>T and NC_000013.11:g.110409638C>T, were found in all VAA-affected individuals, but not in the individual affected by the pseudoaneurysm. The second variant is in a candidate cis-regulatory element in the fourth intron of COL4A2, proximal to COL4A1. As type IV collagens are essential for the stability and integrity of the vascular basement membrane and involved in vascular disease, we conclude that COL4A1 and COL4A2 are strong candidates for VAA susceptibility genes.


  • Germline mutations in young non-smoking women with lung adenocarcinoma

    by Iikki Donner, Riku Katainen, Lauri J. Sipilä, Mervi Aavikko, Eero Pukkala, Lauri A. Aaltonen


  • Candidate susceptibility variants for esophageal squamous cell carcinoma

    by Iikki Donner, Riku Katainen, Tomas Tanskanen, Eevi Kaasinen, Mervi Aavikko, Kristian Ovaska, Miia Artama, Eero Pukkala, Lauri A. Aaltonen

    Esophageal cancer is common worldwide, and often fatal. The major histological subtype is esophageal squamous cell carcinoma (ESCC). ESCC shows familial aggregation and high heritability. Mutations in RHBDF2 cause tylosis, a very rare disorder characterized by high life‐time risk of ESCC, but no other well‐established predisposition genes have been identified. To identify candidate susceptibility variants for ESCC we utilized the Population Information System and the Finnish cancer registry to find study materials by clustering ESCC patients by family name at birth and municipality at birth. We collected archival tissue material and exome sequenced a total of 30 ESCC cases. We prioritized shared, deleterious and rare variants that were significantly enriched in our sample set compared to Finnish and population subset specific controls. Six variants passed filtering, the most frequent being a nonsense mutation in DNAH9 (p.Tyr1573Ter) found in four unrelated patients. DNAH9 has been reported to be frequently lost in ESCC tumors. In this study, one patient's tumor showed loss of the wild type allele of DNAH9 suggesting a tumor suppressive function. A missense variant in GKAP1 was shared by three patients, and missense variants in BAG1, NFX1, FUK, and DDOST by two each. EP300 which has previously been implicated in the genesis of ESCC had a missense variant segregating in three affected individuals in a single family. If validated in independent patient sets, these variants could serve as a tool towards prevention and early diagnosis of ESCC.